Stay updated on BLD-2660 in IPF: Safety, PK, PD Clinical Trial
Sign up to get notified when there's something new on the BLD-2660 in IPF: Safety, PK, PD Clinical Trial page.

Latest updates to the BLD-2660 in IPF: Safety, PK, PD Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase 2a clinical study for BLD-2660 in Idiopathic Pulmonary Fibrosis, while retaining the study's name and revision number.SummaryDifference44%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to BLD-2660 in IPF: Safety, PK, PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLD-2660 in IPF: Safety, PK, PD Clinical Trial page.